Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
Saved in:
| Title: | Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial. |
|---|---|
| Authors: | File, Thomas M1 filet@summahealth.org, Goldberg, Lisa2, Das, Anita3, Sweeney, Carolyn2, Saviski, John2, Gelone, Steven P2, Seltzer, Elyse4, Paukner, Susanne5, Wicha, Wolfgang W5, Talbot, George H6, Gasink, Leanne B2 |
| Source: | Clinical Infectious Diseases. Dec2019, Vol. 69 Issue 11, p1856-1867. 12p. |
| Database: | Environment Complete |
Be the first to leave a comment!
